Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04453072
Other study ID # 19-001992
Secondary ID NCI-2020-02687
Status Recruiting
Phase N/A
First received
Last updated
Start date July 1, 2020
Est. completion date December 31, 2025

Study information

Verified date April 2024
Source Jonsson Comprehensive Cancer Center
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This early phase I trial studies how well a behavioral weight loss intervention consisting of a smartphone application and coaching works for the promotion of weight loss in adolescents and young adults after a stem cell transplant. This study may help researchers learn more about how adolescents and young adults can lose weight and develop healthy eating habits.


Description:

PRIMARY OBJECTIVE: I. To evaluate the effectiveness of an addiction-based weight loss intervention, embodied as a smartphone application (app) with telephone coaching, on weight outcomes of overweight and obese post hematopoietic stem cell transplantation (HSCT) adolescents and young adults. SECONDARY OBJECTIVES: I. To evaluate the changes in metabolic parameters and physical activity levels, in addition to modifications in addictive eating behaviors, motivation, and self-regulatory behaviors. II. To evaluate the feasibility, adherence, and satisfaction of this intervention. OUTLINE: Patients receive an iPhone with W8Loss2Go app, a body scale and a digital food scale to weigh themselves and food daily. Patients interact with coaches via text messages for 4 days weekly and receive weekly 15 minute phone calls for appointment reminders, emotional support, progress discussion, and follow up on items discussed in a prior visit or phone call. Patients also have telemedicine interviews with the coach lasting 60 minutes at 2 and 4 months to elicit both positive and negative impacts on weight management and to identify barriers such as emotional eating, displacement behaviors, poor coping skills to life stressors, and social challenges. Patients who opt to extend the intervention until month 12 attend an additional telemedicine meeting with the coach. Patients also complete questionnaires over approximately 1.5 hours.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date December 31, 2025
Est. primary completion date December 31, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 13 Years to 30 Years
Eligibility Inclusion Criteria: - Patients with a history of HSCT of any type, at least 100 days post-transplant at initial consultation of the study, will be eligible for the study - Patients must classify as obese, represented as body mass index (BMI) >= 85th percentile for age and gender - Patients must also be able to read English since the app intervention is only available in English form - No patients will be excluded for any specific underlying medical condition, but decisions will be made on a case by case basis if a patient's functioning is deemed to significantly interfere with intervention participation - PARENT: - His/her child meets all inclusion criteria - >= 18 years of age - Can speak English Exclusion Criteria: - Patients who are < 100 days post-transplant at initial consultation will not be eligible for the study, but may become eligible if they are > 100 days post-transplant at their next consultation that falls within the enrollment window - Patients whose BMI does not fall under the obese category will be excluded

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Interview
Participate in interviews
Media Intervention
Receive iPhone with W8Loss2Go app
Questionnaire Administration
Complete questionnaires
Scale Device
Receive body scale and food scale
Behavioral:
Telephone-Based Intervention
Receive telephone calls
Other:
Text Message
Receive text message

Locations

Country Name City State
United States UCLA / Jonsson Comprehensive Cancer Center Los Angeles California

Sponsors (2)

Lead Sponsor Collaborator
Jonsson Comprehensive Cancer Center eHealth International, INC.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in body mass index (BMI) status The main outcomes measures will be height (meters), weight (kg), and BMI (kg/m^2). Height will be measured to assess consistency in height measurements. Weight will be measured to assess trends in weight over the time span of the intervention. BMI will be measured as a product of weight and height to obtain an appropriate metric that accounts for these measures, and is the standard measure to assess weight progression in weight intervention studies. Baseline up to 12 months
Secondary Adherence Compliance with app intervention will be measured by daily interaction with the application and the coach. A point system has been designed in the application to measure compliance with the app intervention, measured by +/- weight measured daily, logging of problem foods, logging of snacking panel, and logging of meals. The coach interacts with the participants through text daily, and through phone calls weekly. Up to 12 months
Secondary Fasting lab test analysis: HbA1c HbA1c: Glycated hemoglobin (A1C) test result reflects your average blood sugar level for the past two to three months. Specifically, the A1C test measures what percentage of your hemoglobin is coated with sugar. The healthy range is between 4% and 5.6% At four months up to 12 months
Secondary Fasting lab test analysis: Total cholesterol Total cholesterol: This measures the overall amount of cholesterol in your blood. The healthy range is < 170 mg/dL At four months up to 12 months
Secondary Fasting lab test analysis: Low density lipoprotein LDL: low density lipoprotein (LDL) is the bad cholesterol in your blood. The healthy range is <100 mg/dL At four months up to 12 months
Secondary Fasting lab test analysis: High density lipoprotein HDL: high density lipoprotein (HDL) is the good cholesterol in your blood. The healthy range is > 45 mg/dL At four months up to 12 months
Secondary Fasting lab test analysis: triglycerides TG: triglycerides (TG) are a type of lipid in your blood. The healthy range is < 150 mg/dL At four months up to 12 months
Secondary Fasting lab test analysis: aspartate/alanine aminotransferase AST/ALT: aspartate/alanine aminotransferase (AST/ALT) are liver enzymes to measure liver health. The healthy range or AST is 10-34 IU/L and the healthy range for ALT is 8-37 IU/L. At four months up to 12 months
Secondary Fasting lab test analysis: glucose Glucose: This measures the amount of sugar in your blood. We measure this after fasting for 8 hours. The healthy range is 70-99 mg/dL At four months up to 12 months
Secondary Yale Food Addiction Scale visual analog scale (1: never to 5:always). Higher scores may suggest more addictive like eating Up to 12 months
Secondary Center for epidemiologic studies depression scale 4 categorical options (never/rarely, sometimes, moderately, all of the time). A higher score suggests utility for screening for depression Up to 12 months
Secondary Perceived stress scale Likert Scale (0: never to 4:very often). Higher scores suggests higher stress Up to 12 months
Secondary Satisfaction with program Measured by "Satisfaction Survey". This Likert Scale will be completed by the participant and their parent at the end of the study. This scale uses a Likert Scale where 1 = completely disagree to 7 = completely agree. Higher scores suggest greater satisfaction with the intervention. Up to 12 months
Secondary Demographic questionnaire 10 questions with varying options to inquire about common demographic questions (gender, age, primary language, etc). Questions are descriptive in nature and no score is assigned. Up to 12 months
Secondary Food craving questionnaire Likert scale (1: never to 5: always). A higher score suggests higher degrees of food cravings Up to 12 months
Secondary Binge eating disorder screen 4 categorical options (never/rarely, sometimes, often, always). A higher score suggests utility for screening for binge eating disorder Up to 12 months
Secondary Physical activity questionnaire participants identify number of times (0 to more than 7) that they conducted a particular physical activity in the past 7 days. This includes skipping, rowing, etc. Up to 12 months
Secondary S weight Likert scale (1: strongly disagree to 5: strongly agree). Higher scores indicates more motivation for change in weight Up to 12 months
Secondary Height encounters questionnaire six questions about the participants health care utilization in the past month. Questions are descriptive in nature and no score is assigned. Up to 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2